Gracell Biotechnologies Operating Expenses 2011-2025 | GRCL

Annual Operating Expenses Gracell Biotechnologies

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	214 M	147 M	62.5 M	-	-	-	-	-	-	-

All numbers in CNY currency

Indicator range from annual reports

Maximum	Minimum	Average
214 M	62.5 M	141 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Arbutus Biopharma Corporation ABUS	96.2 M	$ 4.93	4.78 %	$ 818 M	Canada
Aclaris Therapeutics ACRS	92.7 M	$ 3.2	-1.69 %	$ 247 M	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Aptevo Therapeutics APVO	-31.8 M	$ 1.07	-5.75 %	$ 295 K	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	338 M	$ 213.33	-3.22 %	$ 5 B	Danmark
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.13	-4.96 %	$ 7.53 B	Australia
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
BioVie BIVI	18.1 M	$ 1.42	-1.85 %	$ 2.1 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	141 M	-	-15.15 %	$ 60.3 M	Britain
BioNTech SE BNTX	512 M	$ 93.93	-0.93 %	$ 27.2 B	Germany
Aeglea BioTherapeutics AGLE	209 M	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	168 M	$ 26.45	4.67 %	$ 1.28 B	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Anika Therapeutics ANIK	51.6 M	$ 9.6	0.37 %	$ 141 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 0.26	-6.98 %	$ 566 M	Israel
Catalyst Biosciences CBIO	176 M	$ 12.98	-7.91 %	$ 854 M	USA
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Axon Enterprise AXON	1.18 B	$ 548.58	-2.78 %	$ 41.6 B	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	53.7 M	$ 2.37	2.83 %	$ 14.9 M	USA
AstraZeneca PLC AZN	17.6 B	$ 91.59	1.95 %	$ 96.9 B	Britain
Celldex Therapeutics CLDX	58.1 M	$ 27.09	-1.53 %	$ 1.74 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
Burford Capital Limited BUR	106 M	$ 8.97	-0.44 %	$ 1.45 B	Britain
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Biohaven Pharmaceutical Holding Company Ltd. BHVN	1.07 B	$ 11.33	-1.78 %	$ 733 M	USA
Biogen BIIB	5.39 B	$ 175.2	0.63 %	$ 25.5 B	USA
Abeona Therapeutics ABEO	50.6 M	$ 5.07	-5.5 %	$ 108 M	USA
Corcept Therapeutics Incorporated CORT	189 M	$ 87.67	-0.36 %	$ 9.05 B	USA
ADiTx Therapeutics ADTX	27.4 M	$ 1.43	-36.18 %	$ 18.8 K	USA
Cellectar Biosciences CLRB	15.3 M	$ 3.28	-9.39 %	$ 40.1 M	USA
Bellicum Pharmaceuticals BLCM	28.5 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Catalyst Pharmaceuticals CPRX	190 M	$ 24.29	2.84 %	$ 2.88 B	USA